Fujifilm’s recombinant human-type collagen produced with genetic engineering technology
Human-type collagen protein is produced by introducing genes into yeast cells and cultivating in cell cultures with genetic engineering. Configured in an array design with a high level of cell adhesiveness, the resulting recombinant peptide exhibits high levels of quality, safety, efficacy, and processability, offering great potentials in regenerative medicine and other fields.
Various forms (sponge, film, granule, etc.) can be produced to fit specific uses. In fields such as regenerative medicine, these forms can function as a kind of scaffolding for cell growth and multiplication.